chr15:75011883:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr15:75,011,883-75,017,877 |
| hg38 | chr15:74,719,542-74,725,536 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.076 | squamous cell carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | Cardiovascular Diseases | NA | BeFree,GAD | Detail | |
| 0.002 | Neoplastic Cell Transformation | NA | GAD | Detail | |
| 0.003 | cerebral infarction | NA | BeFree,GAD | Detail | |
| 0.014 | Uterine Cervical Neoplasm | NA | BeFree,GAD | Detail | |
| <0.001 | cholelithiasis | NA | BeFree | Detail | |
| 0.002 | intrahepatic cholestasis | NA | GAD | Detail | |
| 0.005 | chorioamnionitis | NA | GAD,LHGDN | Detail | |
| 0.014 | Chromosome Aberrations | NA | GAD | Detail | |
| 0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
| 0.007 | cleft lip | NA | GAD | Detail | |
| 0.007 | cleft palate | NA | GAD | Detail | |
| 0.007 | Cocarcinogenesis | NA | GAD | Detail | |
| <0.001 | colitis | NA | BeFree | Detail | |
| 0.002 | ulcerative colitis | NA | GAD | Detail | |
| 0.008 | Colonic Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Colonic Polyps | NA | GAD | Detail | |
| 0.023 | Colorectal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | Hereditary nonpolyposis colorectal neoplasms | NA | LHGDN | Detail | |
| 0.002 | Connective Tissue Diseases | NA | GAD | Detail | |
| 0.002 | Coronary Arteriosclerosis | The association between CYP1A1 genetic polymorphisms and coronary artery disease... | BeFree | 25189712 | Detail |
| 0.002 | Coronary heart disease | The association between CYP1A1 genetic polymorphisms and coronary artery disease... | BeFree | 25189712 | Detail |
| 0.003 | Crohn Disease | NA | BeFree,GAD | Detail | |
| 0.002 | cystadenocarcinoma | NA | GAD | Detail | |
| 0.120 | Drug Eruptions | NA | CTD_human | Detail | |
| <0.001 | Dermatitis, Atopic | NA | BeFree | Detail | |
| 0.120 | contact dermatitis | NA | CTD_human | Detail | |
| <0.001 | Diabetes | NA | BeFree | Detail | |
| <0.001 | diabetes mellitus | NA | BeFree | Detail | |
| 0.200 | Diabetes Mellitus, Experimental | NA | CTD_human,RGD | Detail | |
| 0.005 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD | Detail | |
| 0.024 | DNA Damage | NA | GAD | Detail | |
| 0.018 | Dysmenorrhea | NA | GAD,LHGDN | Detail | |
| 0.005 | echinococcosis | NA | GAD,LHGDN | Detail | |
| 0.002 | Pathological accumulation of air in tissues | NA | GAD | Detail | |
| 0.019 | Endometrial Neoplasms | NA | GAD,LHGDN | Detail | |
| 0.003 | endometrial hyperplasia | NA | BeFree,GAD | Detail | |
| 0.027 | endometriosis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Disorder of eye | NA | GAD | Detail | |
| 0.002 | Fetal Diseases | NA | GAD | Detail | |
| 0.007 | Fetal Growth Retardation | NA | GAD | Detail | |
| <0.001 | breast fibrocystic disease | NA | BeFree | Detail | |
| 0.003 | Fibrosis | NA | LHGDN | Detail | |
| 0.005 | gallbladder neoplasm | NA | LHGDN | Detail | |
| 0.002 | Female Genital Diseases | NA | GAD | Detail | |
| <0.001 | Glioma | NA | BeFree | Detail | |
| 0.005 | Graves Disease | NA | BeFree,GAD | Detail | |
| 0.120 | Hamartoma | NA | BeFree,CTD_human | Detail | |
| 0.036 | Head and Neck Neoplasms | NA | GAD,LHGDN | Detail | |
| 0.080 | Heart Diseases | NA | RGD | Detail | |
| 0.120 | Cardiomegaly | NA | CTD_human | Detail | |
| <0.001 | Hemorrhoids | NA | BeFree | Detail | |
| 0.002 | hepatitis B | NA | GAD | Detail | |
| 0.003 | hepatitis C | NA | BeFree,LHGDN | Detail | |
| 0.002 | HIV Infections | NA | GAD | Detail | |
| 0.007 | Hodgkin Disease | NA | GAD | Detail | |
| <0.001 | hydronephrosis | NA | BeFree | Detail | |
| 0.002 | Hypercholesterolemia | NA | GAD | Detail | |
| 0.122 | Hypersensitivity | NA | CTD_human,GAD | Detail | |
| 0.124 | Hypertensive disease | Logistic regression was performed to investigate the association of smoking and ... | BeFree,CTD_human,GAD | 25902778 | Detail |
| 0.002 | Hypopharyngeal Neoplasms | NA | GAD | Detail | |
| 0.085 | Inflammation | NA | GAD,RGD | Detail | |
| 0.080 | Kidney Failure, Chronic | NA | RGD | Detail | |
| 0.122 | Kidney Neoplasm | NA | CTD_human,GAD | Detail | |
| 0.019 | Laryngeal neoplasm | NA | GAD | Detail | |
| 0.008 | Fibroid Tumor | NA | BeFree,GAD,LHGDN | Detail | |
| 0.021 | leukemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.007 | chronic lymphocytic leukemia | NA | BeFree,GAD | Detail | |
| 0.004 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| 0.006 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree,GAD | Detail | |
| 0.007 | Leukemia, Myelocytic, Acute | NA | BeFree,GAD,LHGDN | Detail | |
| 0.009 | myeloid leukemia | NA | GAD | Detail | |
| 0.003 | Myeloid Leukemia, Chronic | NA | BeFree,GAD | Detail | |
| <0.001 | leukopenia | NA | BeFree | Detail | |
| 0.003 | Leukoplakia | NA | BeFree,GAD | Detail | |
| 0.005 | Leukoplakia, Oral | NA | BeFree,GAD | Detail | |
| <0.001 | liver cirrhosis | For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decrea... | BeFree | 25024626 | Detail |
| 0.005 | Liver Cirrhosis, Alcoholic | For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decrea... | BeFree,GAD | 25024626 | Detail |
| 0.008 | Liver diseases | NA | BeFree,GAD | Detail | |
| 0.008 | Liver neoplasms | NA | BeFree,GAD | Detail | |
| 0.080 | Liver Neoplasms, Experimental | NA | RGD | Detail | |
| <0.001 | Lung diseases | Our novel results on estradiol metabolism in fetal and early postnatal lung in t... | BeFree | 25399436 | Detail |
| 0.133 | Chronic Obstructive Airway Disease | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| 0.051 | Lung Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
| 0.011 | Lupus Erythematosus, Systemic | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | lymphoma | NA | BeFree,GAD | Detail | |
| 0.002 | Lymphoma, Follicular | NA | GAD | Detail | |
| 0.019 | Lymphoma, Non-Hodgkin | NA | BeFree,GAD | Detail | |
| 0.015 | Malignant neoplasm of stomach | However, available data collected by the study failed to reveal remarkable assoc... | BeFree,GAD | 24969905 | Detail |
| 0.002 | Animal Mammary Neoplasms | NA | GAD | Detail | |
| 0.003 | melanoma | NA | BeFree,GAD | Detail | |
| 0.002 | Mesothelioma | NA | GAD | Detail | |
| 0.040 | Mouth Neoplasms | NA | GAD | Detail | |
| 0.003 | multiple myeloma | NA | BeFree,GAD | Detail | |
| 0.002 | Musculoskeletal Diseases | NA | GAD | Detail | |
| <0.001 | myocardial infarction | NA | BeFree | Detail | |
| 0.080 | Nematode infections | NA | RGD | Detail | |
| 0.002 | Neoplasm Invasiveness | NA | GAD | Detail | |
| <0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
| 0.002 | Neoplasms, Germ Cell and Embryonal | NA | GAD | Detail | |
| 0.002 | Neoplasms, Multiple Primary | NA | GAD | Detail | |
| <0.001 | obesity | NA | BeFree | Detail | |
| 0.122 | Occupational Diseases | NA | CTD_human,GAD | Detail | |
| <0.001 | oral submucous fibrosis | NA | BeFree | Detail | |
| 0.002 | Oropharyngeal Neoplasms | NA | GAD | Detail | |
| 0.003 | osteoporosis | NA | BeFree,LHGDN | Detail | |
| 0.002 | Osteoporosis, Postmenopausal | NA | GAD | Detail | |
| 0.003 | ovarian carcinoma | Increased expression of CYP1 family indicates the possibility of carcinogenesis ... | BeFree | 25448748 | Detail |
| 0.001 | Ovarian Diseases | NA | BeFree | Detail | |
| 0.002 | Pancreatic Neoplasm | NA | GAD | Detail | |
| 0.003 | pancreatitis | NA | LHGDN | Detail | |
| 0.002 | Parkinson disease | NA | GAD | Detail | |
| <0.001 | Peptic Ulcer | NA | BeFree | Detail | |
| 0.005 | periodontitis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Peripheral neuropathy | NA | GAD | Detail | |
| 0.012 | Pharyngeal Neoplasms | NA | GAD,LHGDN | Detail | |
| 0.002 | Pleural Neoplasms | NA | GAD | Detail | |
| 0.003 | pneumonia | NA | BeFree,GAD | Detail | |
| 0.011 | polycystic ovary syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | polycythemia vera | NA | BeFree | Detail | |
| 0.005 | pre-eclampsia | NA | GAD | Detail | |
| 0.005 | Precancerous Conditions | NA | BeFree,GAD | Detail | |
| 0.007 | Pregnancy Complications | NA | GAD | Detail | |
| 0.002 | Pregnancy Complications, Hematologic | NA | GAD | Detail | |
| 0.005 | Preleukemia | NA | GAD | Detail | |
| 0.007 | Prenatal Exposure Delayed Effects | NA | GAD | Detail | |
| 0.137 | Prostatic Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.005 | psoriasis | NA | GAD,LHGDN | Detail | |
| 0.003 | pterygium | NA | BeFree,GAD | Detail | |
| <0.001 | Precocious Puberty | Are CYP1A1, CYP17 and CYP1B1 mutation genes involved on girls with precocious pu... | BeFree | 25150952 | Detail |
| 0.080 | Reperfusion Injury | NA | RGD | Detail | |
| 0.005 | Respiratory Tract Diseases | NA | GAD | Detail | |
| 0.002 | Rhinitis, Allergic, Perennial | NA | GAD | Detail | |
| <0.001 | Seizures | NA | BeFree | Detail | |
| 0.005 | Dermatologic disorders | NA | GAD | Detail | |
| <0.001 | Skin Manifestations | NA | BeFree | Detail | |
| 0.002 | Skin Neoplasms | NA | GAD | Detail | |
| 0.003 | ankylosing spondylitis | NA | BeFree,LHGDN | Detail | |
| 0.017 | Stomach Neoplasms | NA | GAD | Detail | |
| <0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
| 0.003 | sudden infant death syndrome | NA | BeFree,GAD | Detail | |
| 0.005 | Testicular Neoplasms | NA | GAD,LHGDN | Detail | |
| <0.001 | Thromboembolism | NA | BeFree | Detail | |
| 0.002 | Thyroid Neoplasm | NA | GAD | Detail | |
| 0.003 | Thyroid Nodule | NA | BeFree,GAD | Detail | |
| 0.009 | Tobacco use disorder | NA | GAD | Detail | |
| 0.002 | Tuberculosis, Pulmonary | NA | GAD | Detail | |
| 0.004 | Uterine Fibroids | The genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val ... | BeFree,GAD | 24320736 | Detail |
| 0.005 | Uterine Neoplasms | NA | GAD | Detail | |
| <0.001 | Vascular Diseases | NA | BeFree | Detail | |
| <0.001 | Virus Diseases | NA | BeFree | Detail | |
| <0.001 | Wheezing | NA | BeFree | Detail | |
| 0.005 | diffuse large B-cell lymphoma | NA | BeFree,GAD | Detail | |
| <0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
| 0.003 | T-Cell Lymphoma | NA | BeFree,GAD | Detail | |
| 0.120 | Peripheral Vascular Diseases | NA | CTD_human | Detail | |
| <0.001 | Li-Fraumeni syndrome | Using p53 heterozygous mutant epithelial cells from patients with Li-Fraumeni sy... | BeFree | 24736433 | Detail |
| 0.003 | Arthritis, Reactive | NA | BeFree,LHGDN | Detail | |
| 0.006 | Non-small cell lung carcinoma | In this study, CYP1A1 (Ile462Val), CYP1B1(Asn453Ser), GST M1, GSTP1 exon 5 (Ile1... | BeFree | 20845989 | Detail |
| 0.001 | acute leukemia | NA | BeFree | Detail | |
| <0.001 | Depressive Symptoms | NA | BeFree | Detail | |
| 0.003 | Squamous cell carcinoma of lung | NA | BeFree | Detail | |
| <0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
| 0.019 | Premature Birth | NA | GAD | Detail | |
| <0.001 | Oral Cavity Carcinoma | NA | BeFree | Detail | |
| 0.004 | Uterine Fibroids | The genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-... | BeFree | 24777039 | Detail |
| 0.005 | Adenocarcinoma of lung (disorder) | NA | BeFree,GAD | Detail | |
| 0.007 | Malignant neoplasm of mouth | The results also suggested significant association between tobacco habits, espec... | BeFree,GAD | 23444898 | Detail |
| 0.007 | Malignant neoplasm of mouth | CYP1A1 polymorphism interactions with smoking status in oral cancer risk: eviden... | BeFree,GAD | 25106409 | Detail |
| 0.007 | Malignant neoplasm of mouth | Our findings suggest that presence of GSTM1 and/or GSTT1 null genotypes along wi... | BeFree,GAD | 25735346 | Detail |
| 0.007 | Malignant neoplasm of mouth | Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A... | BeFree,GAD | 26166128 | Detail |
| <0.001 | Malignant neoplasm of pharynx | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of gallbladder | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of testis | NA | BeFree | Detail | |
| 0.005 | Malignant neoplasm of brain | NA | BeFree,GAD | Detail | |
| <0.001 | endometriosis of ovary | NA | BeFree | Detail | |
| 0.002 | iron deficiency anemia | NA | GAD | Detail | |
| 0.120 | Dermatitis, Allergic Contact | NA | CTD_human | Detail | |
| 0.002 | hidradenitis suppurativa | NA | GAD | Detail | |
| <0.001 | Fibroadenoma | NA | BeFree | Detail | |
| 0.002 | Adenocarcinoma, Clear Cell | NA | GAD | Detail | |
| 0.002 | Carcinoma, Endometrioid | NA | GAD | Detail | |
| 0.002 | Cystadenocarcinoma, Serous | NA | GAD | Detail | |
| 0.008 | Cervical Intraepithelial Neoplasia | NA | BeFree,GAD | Detail | |
| 0.002 | Squamous Cell Neoplasms | NA | GAD | Detail | |
| <0.001 | Angiofibroma | NA | BeFree | Detail | |
| <0.001 | childhood brain tumor | NA | BeFree | Detail | |
| <0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
| 0.005 | Lip and oral cavity carcinoma | The results also suggested significant association between tobacco habits, espec... | BeFree | 23444898 | Detail |
| 0.005 | Lip and oral cavity carcinoma | CYP1A1 polymorphism interactions with smoking status in oral cancer risk: eviden... | BeFree | 25106409 | Detail |
| 0.005 | Lip and oral cavity carcinoma | Our findings suggest that presence of GSTM1 and/or GSTT1 null genotypes along wi... | BeFree | 25735346 | Detail |
| 0.005 | Lip and oral cavity carcinoma | Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A... | BeFree | 26166128 | Detail |
| <0.001 | Malignant neoplasm of female breast | NA | BeFree | Detail | |
| 0.002 | gallbladder carcinoma | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| 0.002 | Alcohol-Related Disorders | NA | GAD | Detail | |
| 0.124 | Malignant neoplasm of lung | Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 ... | BeFree,GAD | 25040976 | Detail |
| 0.124 | Malignant neoplasm of lung | We evaluated 23 single nucleotide polymorphisms (SNPs) in the five nicotinic rec... | BeFree,GAD | 25233467 | Detail |
| 0.124 | Malignant neoplasm of lung | The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, ... | BeFree,GAD | 25388590 | Detail |
| 0.005 | age related macular degeneration | NA | GAD | Detail | |
| 0.080 | Acute Lung Injury | NA | RGD | Detail | |
| 0.200 | Hyperoxia | NA | CTD_human,RGD | Detail | |
| 0.080 | Sepsis | NA | RGD | Detail | |
| <0.001 | Carcinoma of ampulla of Vater | NA | BeFree | Detail | |
| <0.001 | Carcinoma, Small Cell | NA | BeFree | Detail | |
| <0.001 | Chloracne | NA | BeFree | Detail | |
| <0.001 | Xeroderma pigmentosum, group A | NA | BeFree | Detail | |
| 0.120 | Lung Injury | NA | CTD_human | Detail | |
| 0.017 | Cancer of Head and Neck | Similarly, tobacco-betel quid chewers carrying CYP1A1 TC/CC + GSTM1 null genotyp... | BeFree,GAD | 25724184 | Detail |
| 0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
| <0.001 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
| 0.002 | Focal Nodular Hyperplasia | NA | GAD | Detail | |
| <0.001 | adenocarcinoma in situ | NA | BeFree | Detail | |
| <0.001 | Thyroid associated opthalmopathies | NA | BeFree | Detail | |
| <0.001 | Glaucoma, Primary Open Angle | The frequency of the homozygous wild-type (w1/w1) CYP1A1 gene among patients wit... | BeFree | 25501250 | Detail |
| <0.001 | Chronic liver disease | NA | BeFree | Detail | |
| <0.001 | endometriosis of uterus | NA | BeFree | Detail | |
| <0.001 | Human papilloma virus infection | NA | BeFree | Detail | |
| 0.007 | Malignant neoplasm of liver | NA | GAD | Detail | |
| 0.003 | malignant mesothelioma | NA | BeFree,GAD | Detail | |
| 0.007 | Malignant neoplasm of pancreas | NA | BeFree,GAD | Detail | |
| 0.075 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
| 0.002 | Pancreatitis, Alcoholic | NA | GAD | Detail | |
| 0.009 | endometrial carcinoma | NA | BeFree,GAD | Detail | |
| <0.001 | Hepatitis B, Chronic | NA | BeFree | Detail | |
| <0.001 | Environmental Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | Palmar-plantar erythrodysesthesia syndrome | NA | BeFree | Detail | |
| 0.003 | Thyroid carcinoma | NA | BeFree,GAD | Detail | |
| 0.005 | Menopause present (finding) | NA | GAD | Detail | |
| <0.001 | Carcinoma of larynx | NA | BeFree | Detail | |
| 0.009 | Carcinogenesis | Increased expression of CYP1 family indicates the possibility of carcinogenesis ... | BeFree | 25448748 | Detail |
| <0.001 | Chemical Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | Tumor Initiation | NA | BeFree | Detail | |
| 0.006 | prostate carcinoma | NA | BeFree | Detail | |
| <0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| 0.024 | breast carcinoma | 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates estradiol-induced aldehydic DNA le... | BeFree | 23700305 | Detail |
| 0.024 | breast carcinoma | Here, we focus on recent advances in the understanding of molecular mechanisms t... | BeFree | 25257533 | Detail |
| 0.044 | Carcinoma of lung | Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 ... | BeFree | 25040976 | Detail |
| 0.044 | Carcinoma of lung | We evaluated 23 single nucleotide polymorphisms (SNPs) in the five nicotinic rec... | BeFree | 25233467 | Detail |
| 0.044 | Carcinoma of lung | The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, ... | BeFree | 25388590 | Detail |
| <0.001 | colon carcinoma | NA | BeFree | Detail | |
| 0.003 | stomach carcinoma | However, available data collected by the study failed to reveal remarkable assoc... | BeFree | 24969905 | Detail |
| 0.003 | Carcinoma of bladder | NA | BeFree | Detail | |
| 0.003 | skin carcinoma | NA | BeFree,GAD | Detail | |
| <0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
| <0.001 | bile duct carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
| <0.001 | Pharyngeal Carcinoma | NA | BeFree | Detail | |
| <0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
| 0.005 | hypospadias | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | Helicobacter pylori infection | NA | BeFree,GAD | Detail | |
| <0.001 | Smoker's lung | NA | BeFree | Detail | |
| <0.001 | Sickle Cell Dactylitis | NA | BeFree | Detail | |
| <0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Testicular malignant germ cell tumor | NA | BeFree | Detail | |
| <0.001 | breast adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinogenicity | In conclusion, the present work shows a strong evidence that MET inhibits the DM... | BeFree | 25697376 | Detail |
| <0.001 | Malignant melanoma, metastatic | NA | BeFree | Detail | |
| 0.010 | ovarian neoplasm | NA | BeFree,GAD | Detail | |
| 0.002 | Genomic Instability | NA | GAD | Detail | |
| 0.002 | Microsatellite Instability | NA | GAD | Detail | |
| <0.001 | cholecystolithiasis | NA | BeFree | Detail | |
| 0.003 | Acute coronary syndrome | NA | BeFree,GAD | Detail | |
| <0.001 | Polyp of large intestine | NA | BeFree | Detail | |
| <0.001 | Nosocomial pneumonia | NA | BeFree | Detail | |
| 0.005 | Papillomavirus Infections | NA | GAD | Detail | |
| 0.017 | Malignant neoplasm of ovary | Increased expression of CYP1 family indicates the possibility of carcinogenesis ... | BeFree,GAD | 25448748 | Detail |
| 0.005 | Squamous cell carcinoma of the head and neck | Meta-analyses of the effect of CYP1A1 and CYP2D6 polymorphisms on the risk of he... | BeFree,GAD | 25138301 | Detail |
| 0.005 | Squamous cell carcinoma of the head and neck | LR analysis revealed that subjects carrying CYP1A1 TC/CC + GSTM1 null genotypes ... | BeFree,GAD | 25724184 | Detail |
| 0.002 | Systemic arterial pressure | NA | GAD | Detail | |
| 0.002 | Mesothelioma (malignant, clinical disorder) (disorder) | NA | GAD | Detail | |
| <0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| 0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
| <0.001 | Cervical Squamous Intraepithelial Neoplasia | NA | BeFree | Detail | |
| 0.001 | childhood leukemia | NA | BeFree | Detail | |
| <0.001 | gastric cardia carcinoma | NA | BeFree | Detail | |
| <0.001 | Hereditary Nonpolyposis Colorectal Cancer | NA | BeFree | Detail | |
| <0.001 | Infiltrating Cervical Carcinoma | NA | BeFree | Detail | |
| 0.005 | Testicular Germ Cell Tumor | NA | GAD | Detail | |
| <0.001 | renal carcinoma | NA | BeFree | Detail | |
| 0.120 | Micronuclei, Chromosome-Defective | NA | CTD_human | Detail | |
| 0.159 | Mammary Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| <0.001 | Tumor Promotion | NA | BeFree | Detail | |
| <0.001 | Cirrhosis | For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decrea... | BeFree | 25024626 | Detail |
| <0.001 | Penile hypospadias | NA | BeFree | Detail | |
| <0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| <0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
| 0.007 | Mammographic Density | NA | BeFree,GAD | Detail | |
| <0.001 | Aryl Hydrocarbon Hydroxylase Inducibility | NA | BeFree | Detail | |
| 0.004 | uterine corpus cancer | NA | BeFree | Detail | |
| 0.017 | coronary artery disease | The association between CYP1A1 genetic polymorphisms and coronary artery disease... | BeFree,GAD,LHGDN | 25189712 | Detail |
| 0.017 | coronary artery disease | Moreover, it also shows the effect of smoking-gene interaction on CAD risk, wher... | BeFree,GAD,LHGDN | 25902778 | Detail |
| 0.030 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD,LHGDN | Detail | |
| 0.134 | liver carcinoma | However, available data collected by the study failed to reveal remarkable assoc... | BeFree,CTD_human,GAD | 24969905 | Detail |
| 0.134 | liver carcinoma | For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decrea... | BeFree,CTD_human,GAD | 25024626 | Detail |
| 0.134 | liver carcinoma | Association between the CYP1A1 polymorphisms and hepatocellular carcinoma: a met... | BeFree,CTD_human,GAD | 25730047 | Detail |
| 0.002 | caffeine stimulant related disorder | NA | GAD | Detail | |
| <0.001 | Prostate cancer, familial | NA | BeFree | Detail | |
| 0.005 | myelodysplastic syndrome | NA | GAD | Detail | |
| 0.002 | Infection | NA | GAD | Detail | |
| 0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
| <0.001 | Lymphoblastic leukemia in children | NA | BeFree | Detail | |
| 0.007 | colorectal carcinoma | The CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.8... | BeFree | 20937634 | Detail |
| 0.072 | colorectal cancer | The CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.8... | BeFree | 20937634 | Detail |
| 0.002 | Congenital Abnormality | NA | GAD | Detail | |
| 0.122 | Spontaneous abortion | NA | CTD_human,GAD | Detail | |
| 0.002 | Abortion, Habitual | NA | GAD | Detail | |
| 0.014 | adenocarcinoma | NA | BeFree,GAD | Detail | |
| 0.008 | adenoma | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | Alcoholic Intoxication, Chronic | NA | GAD | Detail | |
| 0.005 | Alzheimer's disease | NA | GAD | Detail | |
| 0.003 | amyotrophic lateral sclerosis | NA | BeFree,GAD | Detail | |
| 0.007 | aplastic anemia | NA | GAD,LHGDN | Detail | |
| 0.003 | arteriosclerosis | NA | BeFree,GAD | Detail | |
| 0.120 | Arteritis | NA | CTD_human | Detail | |
| 0.005 | arthritis | NA | GAD | Detail | |
| 0.005 | Arthritis, Psoriatic | NA | BeFree,GAD,LHGDN | Detail | |
| 0.010 | asthma | NA | BeFree,GAD | Detail | |
| 0.008 | atherosclerosis | NA | BeFree,GAD | Detail | |
| 0.002 | autistic disorder | NA | GAD | Detail | |
| 0.002 | Barrett esophagus | NA | GAD | Detail | |
| <0.001 | Basal Cell Nevus Syndrome | NA | BeFree | Detail | |
| 0.005 | Behcet Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| 0.030 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
| 0.003 | Bladder Neoplasm | NA | BeFree,LHGDN | Detail | |
| 0.002 | Blood Coagulation Disorders | NA | GAD | Detail | |
| <0.001 | borderline personality disorder | NA | BeFree | Detail | |
| <0.001 | Brain Neoplasms | NA | BeFree | Detail | |
| 0.104 | Malignant neoplasm of breast | 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates estradiol-induced aldehydic DNA le... | BeFree,GAD | 23700305 | Detail |
| 0.104 | Malignant neoplasm of breast | Here, we focus on recent advances in the understanding of molecular mechanisms t... | BeFree,GAD | 25257533 | Detail |
| 0.002 | bronchitis | NA | GAD | Detail | |
| <0.001 | bronchopulmonary dysplasia | NA | BeFree | Detail | |
| <0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| 0.004 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| <0.001 | female breast carcinoma | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of larynx | NA | BeFree,GAD | Detail | |
| <0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
| 0.002 | basal cell carcinoma | NA | GAD | Detail | |
| <0.001 | Bronchogenic Carcinoma | NA | BeFree | Detail | |
| 0.005 | mucinous adenocarcinoma | NA | GAD | Detail | |
| 0.006 | Non-small cell lung carcinoma | NA | BeFree,GAD | Detail | |
| 0.003 | Carcinoma, Papillary | NA | BeFree,GAD | Detail | |
| 0.084 | renal cell carcinoma | Association between cytochrome P450 1A1 (CYP1A1) gene polymorphisms and the risk... | BeFree,GAD,RGD | 25630554 | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Ha... | DisGeNET | Detail |
| The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Ha... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Logistic regression was performed to investigate the association of smoking and selected susceptibil... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decreased 90% in HCC, 80% ... | DisGeNET | Detail |
| For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decreased 90% in HCC, 80% ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our novel results on estradiol metabolism in fetal and early postnatal lung in the context of hypero... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| However, available data collected by the study failed to reveal remarkable associations of GC or HC ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Increased expression of CYP1 family indicates the possibility of carcinogenesis by exposure of xenob... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Are CYP1A1, CYP17 and CYP1B1 mutation genes involved on girls with precocious puberty? A pilot study... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The genetic polymorphisms of IVS1+2329C>T and Val158Met loci in COMT, Ile462Val and Gly45Asp loci in... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Using p53 heterozygous mutant epithelial cells from patients with Li-Fraumeni syndrome, we show that... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In this study, CYP1A1 (Ile462Val), CYP1B1(Asn453Ser), GST M1, GSTP1 exon 5 (Ile105Val) and exon 6(Al... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The genetic polymorphism of rs3087869 (IVS1+2329C>T) (OR 3.200, 95% CI 1.614-6.345) and rs4680 (V... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The results also suggested significant association between tobacco habits, especially chewing, varia... | DisGeNET | Detail |
| CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiologi... | DisGeNET | Detail |
| Our findings suggest that presence of GSTM1 and/or GSTT1 null genotypes along with variant alleles o... | DisGeNET | Detail |
| Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The results also suggested significant association between tobacco habits, especially chewing, varia... | DisGeNET | Detail |
| CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiologi... | DisGeNET | Detail |
| Our findings suggest that presence of GSTM1 and/or GSTT1 null genotypes along with variant alleles o... | DisGeNET | Detail |
| Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes ... | DisGeNET | Detail |
| We evaluated 23 single nucleotide polymorphisms (SNPs) in the five nicotinic receptor related genes ... | DisGeNET | Detail |
| The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, CYP2D6*4, GSTP1, GST... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Similarly, tobacco-betel quid chewers carrying CYP1A1 TC/CC + GSTM1 null genotypes also had several ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The frequency of the homozygous wild-type (w1/w1) CYP1A1 gene among patients with primary open-angle... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Increased expression of CYP1 family indicates the possibility of carcinogenesis by exposure of xenob... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates estradiol-induced aldehydic DNA lesions in human breas... | DisGeNET | Detail |
| Here, we focus on recent advances in the understanding of molecular mechanisms that mediate this cro... | DisGeNET | Detail |
| Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes ... | DisGeNET | Detail |
| We evaluated 23 single nucleotide polymorphisms (SNPs) in the five nicotinic receptor related genes ... | DisGeNET | Detail |
| The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, CYP2D6*4, GSTP1, GST... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| However, available data collected by the study failed to reveal remarkable associations of GC or HC ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In conclusion, the present work shows a strong evidence that MET inhibits the DMBA-mediated carcinog... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Increased expression of CYP1 family indicates the possibility of carcinogenesis by exposure of xenob... | DisGeNET | Detail |
| Meta-analyses of the effect of CYP1A1 and CYP2D6 polymorphisms on the risk of head and neck squamous... | DisGeNET | Detail |
| LR analysis revealed that subjects carrying CYP1A1 TC/CC + GSTM1 null genotypes had 3.52-fold (P < 0... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decreased 90% in HCC, 80% ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Ha... | DisGeNET | Detail |
| Moreover, it also shows the effect of smoking-gene interaction on CAD risk, where the CYP1A1 MspI po... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| However, available data collected by the study failed to reveal remarkable associations of GC or HC ... | DisGeNET | Detail |
| For cytochrome P450 enzymes 1 (CYP1) family, the expression of CYP1A2 was decreased 90% in HCC, 80% ... | DisGeNET | Detail |
| Association between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.9... | DisGeNET | Detail |
| The CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.9... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates estradiol-induced aldehydic DNA lesions in human breas... | DisGeNET | Detail |
| Here, we focus on recent advances in the understanding of molecular mechanisms that mediate this cro... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between cytochrome P450 1A1 (CYP1A1) gene polymorphisms and the risk of renal cell carci... | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs1065827 dbSNP
- Genome
- hg19
- Position
- chr15:75,011,883-75,017,877
- Variant Type
- snv
Genome browser